Skip to main content
Clinical Trials/NCT04040127
NCT04040127
Withdrawn
Phase 2

Effect of Residual Dental Pulp Tissue and Cord Blood Stem Cells on Regeneration of Dental

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Irreversible Pulpitis
Sponsor
University of California, San Francisco
Primary Endpoint
Regeneration of pulp
Status
Withdrawn
Last Updated
5 years ago

Overview

Brief Summary

The experiments outlined in this proposal are designed to test the hypothesis that the in vivo injection of cord blood stem cells (InvitRx®) into the root canal system will facilitate teeth initially diagnosed with irreversible pulpitis, to form normal healthy pulpal tissue.

Detailed Description

Patients will be recruited from the various dental clinics at UCSF (student clinic, Advanced Education in General Dentistry clinic, post-graduate endodontics clinic, etc) that meet the inclusion and exclusion criteria. Patients in the control group will have root canal therapy initiated; instrumentation and cleaning up to 4mm from the radiographic apex. Bleeding will be induced and blood clot formed 3mm from the CEJ. MTA followed by glass ionomer and composite will be placed over the clot. Patients in the experimental group will have root canal therapy initiatied; instrumentation and cleaning up to 4mm from the radiographic apex. Bleeding will be induced and blood clot formed 3mm from the CEJ. 1 cc (30 million cord blood stem cells) will then be injected into the clot formation. MTA followed by glass ionomer and composite will be placed over the clot.

Registry
clinicaltrials.gov
Start Date
September 1, 2019
End Date
February 28, 2020
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • A. Patients must be systemically healthy, Class I dental category. B. Involved teeth must have no periodontal disease detectible by periodontal examination.
  • C. Patients must present without radiographic signs of endodontic disease (i.e. no periapical radiolucencies).

Exclusion Criteria

  • A. Presence of any disease or medication that alters the immune system or interferes with healing ability B. Smokers (more than 10 cigarettes per day) C. External or internal tooth resorption D. Tooth perforation from the pulp cavity through the tip of the root exposing the tissue to material in the oral cavity.
  • E. Pregnant or nursing mothers because hormonal factors may influence the condition.
  • F. Allergies or adverse reactions to local anesthetic medications G. Patients under the age of
  • H. Patients with an ASA Classification II or higher

Outcomes

Primary Outcomes

Regeneration of pulp

Time Frame: 6-9 months

Absence of clinical symptoms and signs as well as response to thermal testing.

Similar Trials